TCV (Tanmiya Capital Ventures)

TCV, or Tanmiya Capital Ventures, is a Cairo-based private equity firm backed by the Egyptian American Enterprise Fund that invests in mid-cap businesses across healthcare and education to drive regional capacity. Check sizes are in the $5M to $25M range at growth stage, and the firm’s healthcare interest is concentrated in healthcare infrastructure and tech-enabled care delivery rather than software or AI platforms. This is a control-and-influence PE vehicle, not a venture fund, and the implications are familiar: TCV invests in established operating businesses with revenue, EBITDA, and a defined growth thesis that institutional capital and governance discipline can accelerate. The geographic focus is Egypt and the broader MENA region, with the EAEF backing giving the firm credibility with development-finance peers and with US-aligned Egyptian institutional networks. The right founder profile is an operator already running a profitable or near-profitable healthcare business in Egypt or the Levant, ideally a hospital group, specialty clinic chain, diagnostic network, or pharmacy operator, who needs growth capital paired with institutional governance and is open to a meaningful equity stake going to a financial partner with board influence. The wrong fit is an early-stage software startup or an AI/ML platform; TCV is not where venture-style technology bets live. The right entry path is through Cairo-based corporate finance advisors, regional banks, family-office networks, and through introductions from EAEF-affiliated investors and co-investors at firms like Compass Capital, Africinvest, and Mediterrania Capital. When pitching, lead with audited financials, EBITDA trajectory, the regulatory environment in your specific healthcare segment, and the operational improvements that capital plus governance support will unlock. Articulate the exit thesis early; PE funds underwrite to defined holding periods. Caveats: TCV is a smaller PE vehicle relative to global mid-market firms, and exits in Egyptian healthcare have been less liquid than in other emerging markets, so founders and TCV alike must underwrite to either trade-sale or local-listing scenarios with realistic timelines. Use TCV when you are running an institutional-ready Egyptian or MENA healthcare operating business and need a growth-stage PE partner with American development-finance backing.